[Treatment of virilized women with intramuscular administration of cyproterone acetate].


Management of hirsutism with high-dose oral cyproterone acetate (CPA) is associated with a failure rate of about 30%. The present investigation analyses the efficacy of parenteral CPA administration in non-tumorous hyperandrogenism. Medium-dose CPA (300 mg) was injected intramuscularly once per month, followed by oral ethinylestradiol (40 micrograms daily… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.